Citizens recently reaffirmed its positive view on Xometry (XMTR) after the company announced a leadership change, with co founder and CEO Randy Altschuler moving to executive chairman and president Sanjeev Singh Sahni set to become CEO.

The leadership transition headlines come after a sharp 37.5% year to date share price decline to US$39.20 and a 32% 30 day share price pullback. However, the 1 year total shareholder return of 52.4% and 3 year total shareholder return of around 2.7x still point to a strong longer term picture, suggesting sentiment has cooled recently even as investors who held on over multiple years remain ahead.

If this leadership change has you thinking about where else AI driven platforms could reshape manufacturing and automation, it may be worth scanning the market using our 31 robotics and automation stocks

With the stock down sharply this year, yet still well ahead over 12 months and trading below the average analyst price target, the key question is whether Xometry is now undervalued or if the market is already accounting for its future growth.

Most Popular Narrative: 37.1% Undervalued

The most followed narrative on Xometry places fair value at $62.33 per share versus the last close at $39.20, framing a sizeable valuation gap for investors to assess.

Accelerated adoption of digital platforms for manufacturing procurement highlighted by growing enterprise engagement, robust increases in active buyers, and technology advances such as instant quoting, expanded Teamspace, and deeper system integrations is driving meaningful revenue growth and supporting expectations for continued top line expansion. The rapid deployment of AI and machine learning across pricing, supplier selection, and workflow automation is substantially improving efficiency, optimizing gross margin, and providing significant operating leverage, positioning the company for margin expansion and improving EBITDA.

Curious what earnings profile and margin path are baked into that $62.33 figure? The narrative leans on compounded revenue growth, rising profitability, and a rich future profit multiple to bridge the gap to its fair value.

Result: Fair Value of $62.33 (UNDERVALUED)

However, this upside view still hinges on successful international expansion, and on ongoing heavy AI investment not eroding margins or forcing further equity dilution.

Another View: DCF Paints A Different Picture

While the popular narrative points to a fair value of $62.33 and labels Xometry as 37.1% undervalued, the SWS DCF model lands in a very different place. On that basis, the estimated value is $25.77 per share, which suggests the stock could be overvalued instead. Consider which set of assumptions you trust more for your own framework.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Xometry for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Feeling torn between the upside story and the more cautious valuation work? Take a closer look at the underlying data now and shape your own view by weighing up the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Xometry has sharpened your interest, do not stop here. Use the Simply Wall Street Screener to spot other opportunities that could suit your approach.

• Target income potential by checking out companies viewed as resilient payers through the 13 dividend fortresses.
• Hunt for quality at a reasonable entry point by scanning the 52 high quality undervalued stocks.
• Prioritize capital preservation by reviewing companies that appear steadier on key risk metrics in the 68 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.